Loren Saulsberry is the Assistant Program Leader of the Cancer Prevention and Control Program within the UChicago Medicine Comprehensive Cancer Center and the Assistant Director of Diversity Studies in the UChicago Center for Personalized Therapeutics. As a health policy and health services researcher, Dr. Saulsberry investigates the experiences of vulnerable populations managing chronic conditions, especially those underrepresented and medically underserved. Her research interests include: (1) health policies and services that impact precision medicine delivered across the care continuum from prevention and early detection to cancer outcomes, (2) the relationships between politics and health communication, (3) the determinants contributing to health disparities affecting diverse populations, especially across race/ethnicity and socioeconomic status.
Harvard University
Boston, MA
Ph.D. - Health Policy
2017
Wellesley College
Wellesley, MA
B.A. - Neuroscience, English
2010
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information.
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information. Clin Pharmacol Ther. 2025 Jun; 117(6):1793-1802.
PMID: 40033674
In Reply to Dimitroyannis.
In Reply to Dimitroyannis. Pract Radiat Oncol. 2025 Mar-Apr; 15(2):212-213.
PMID: 40155183
Socioeconomic and Geographic Differences in Mammography Trends Following the 2009 USPSTF Policy Update.
Socioeconomic and Geographic Differences in Mammography Trends Following the 2009 USPSTF Policy Update. JAMA Netw Open. 2025 Feb 03; 8(2):e2458141.
PMID: 39908017
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions.
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
PMID: 38271180
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders.
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders. JAMA Psychiatry. 2024 Oct 01; 81(10):976-984.
PMID: 39046728
Expenditures and Use of Hypofractionated Radiation Therapy Treating Breast Cancer Among Medicare Advantage Enrollees, 2009 to 2017.
Expenditures and Use of Hypofractionated Radiation Therapy Treating Breast Cancer Among Medicare Advantage Enrollees, 2009 to 2017. Adv Radiat Oncol. 2024 Sep; 9(9):101568.
PMID: 39176100
Assessment of unmeasured confounding in the association between perceived discrimination and mental health in a predominantly African American cohort using g-estimation.
Assessment of unmeasured confounding in the association between perceived discrimination and mental health in a predominantly African American cohort using g-estimation. Int J Epidemiol. 2024 Jun 12; 53(4).
PMID: 38961645
Advancing genomics to improve health equity.
Advancing genomics to improve health equity. Nat Genet. 2024 May; 56(5):752-757.
PMID: 38684898
Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis.
Geographic and Physician-Level Variation in the Use of Hypofractionated Radiation Therapy for Breast Cancer in the U.S.: A Cross-Classified Multilevel Analysis. Adv Radiat Oncol. 2024 Jun; 9(6):101487.
PMID: 38725638
Medicaid Privatization: Has the Invisible Hand Led Us Astray?
Medicaid Privatization: Has the Invisible Hand Led Us Astray? JCO Oncol Pract. 2024 May; 20(5):599-601.
PMID: 38364195
K Award
Central Society for Clinical and Translational Research (CSCTR)
2022
Human Genetics Scholar
American Society of Human Genetics (ASHG)
2020 - 2022
North Coast Conference on Precision Medicine Travel Award
Cleveland Institute for Computational Biology, Case Western Reserve University
2019